Divestment
ActoGeniX (Intrexon)
ActoGeniX was a biotechnology company pioneering oral delivery of therapeutic proteins through its ActoBiotics platform.
Key Facts
- Sector
Life Sciences
- Country
Belgium
- Fund
LSP 3
- Entry
2006
- Exit
2015
Responsible Partner
News
Do You Want to Know More?
We are eager to explore how we can achieve great things together.